Trial Profile
Mitochondrial Dysfunction in Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Icatibant (Primary)
- Indications Mitochondrial disorders
- Focus Therapeutic Use
- Acronyms MitoCKD
- 03 Apr 2019 Status changed from active, no longer recruiting to completed.
- 01 Aug 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 08 Jun 2017 New trial record